Abstract:Securinega alkaloids represent a class of plant secondary metabolites with intriguing bridged tetracyclic structures and promising biological activities. Despite extensive synthetic efforts and a number of innovative total syntheses, no relevant biosynthetic genes have been reported to date. In this study, fluesuffine A (1), a C-2 and C-3 functionalized derivative of Securinega alkaloids with a fused 5/5/5/6/5/6/5 congested heptacyclic ring system, was isolated from Flueggea suffruticosa. In the biogenetic study of 1, we found a berberine bridge enzyme (BBE)-like enzyme (FsBBE), which could efficaciously catalyze the condensation of allosecurinine and l-ascorbic acid (l-AA) or dehydroascorbic acid (DHA), resulting in the chemical skeleton of 1. FsBBE also could catalyze the condensation of allosecurinine and isoascorbic acid to form another unnatural Securinega alkaloid fluesuffine B (2), an epimer of 1. Moreover, the catalytic mechanism study of FsBBE revealed the existence of an enamine intermediate (3), which was previously proposed as a key intermediate in the biosynthesis of C-2 and C-3 functionalized derivatives of Securinega alkaloids. The formation of 3 suggested that the epimers were synthesized via an intermolecular enamine-type addition reaction. Hence, our findings provide further insight into the biosynthesis of C-2 and C-3 functionalized derivatives of Securinega alkaloids and expand the diversity of ascorbylated natural product.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acscatal.1c01514?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acscatal.1c01514</a>.General experimental procedures; CDS sequence of fsbbe; total protein purification and recombinant protein figures; evolution and homology analysis of FsBBE; NMR and MS data of compounds 1–3; IR, UV, and X-ray crystallographic data of compounds 1 and 2; product characterization; candidate gene list and their different expression analyses; cytotoxicity data; and supplement schemes and primers used in the study (<a class="ext-link" href="/doi/suppl/10.1021/acscatal.1c01514/suppl_file/cs1c01514_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

Natural product anticipation via chemical synthesis: Discovery of two new securinega alkaloids

Discovery and Efficient Synthesis of a Biologically Active Alkaloid Inspired by Thiostrepton Biosynthesis

Privileged Biorenewable Secologanin-Based Diversity-Oriented Synthesis for Pseudo-Natural Alkaloids: Uncovering Novel Neuroprotective and Antimalarial Frameworks

Natural product anticipation through synthesis

Transformation of (allo)securinine to (allo)norsecurinine via a molecular editing strategy

Discovery and Biosynthesis of Ascorbylated Securinega Alkaloids

Synthesis and Structure Revision of Securingine E

Biomimetic synthesis of fluvirosaone A

The formal total synthesis of securinine]

Total Synthesis of (–)-Securingine G

Bioactivities and mechanism of action of securinega alkaloids derivatives reported prior to 2022

Total Synthesis of (-)-Flueggeacosine C

Natural product synthesis: A platform for discovery in chemistry and biology

Antitumor Agents. 274. A New Synthetic Strategy for E-ring SAR Study of Antofine and Cryptopleurine Analogues.

Targeted Genome Mining—From Compound Discovery to Biosynthetic Pathway Elucidation

An oxidative photocyclization approach to the synthesis of Securiflustra securifrons alkaloids

Discovery and Biosynthesis of Sulfenicin and Its New-to-Nature Acylsulfenic Acid Functional Group

Total synthesis of securinine]

Syntheses of Biological Active Natural Products and Natural Product-Like Molecules

Recent Advances in Combinatorial Biosynthesis for Drug Discovery.

Biosynthetic potential-based strain prioritization for natural product discovery: a showcase for diterpenoid-producing actinomycetes.